Genomic Health (GHDX) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts GHDX Hot Sheet
Price: $63.44 --0%
Financial Fact:
Income (loss) from operations: -16.92M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Income (loss) from operations: -16.92M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Genomic Health (NASDAQ: GHDX) reported Q2 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $85.5 million versus the consensus estimate of $86.08 million.
GUIDANCE:
Genomic Health sees FY2017 revenue of $345-355 million, versus the consensus of $356.1 million.
For earnings history and earnings-related data on Genomic Health (GHDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Advance Auto Parts (AAP) Tops Q2 EPS by 22c; lifrs profit guidance
- ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
